Key Highlights

  • Marvell (NASDAQ:MRVL) fell about 13% to USD 218.95 on October 29, 2026 after a media report of advanced talks to buy Lumentum, a deal that has not been announced.
  • The deal could reportedly be announced as soon as next week, but no company statement confirming talks, price or terms was found for this article.
  • Marvell has a market Capitalization just over USD 220 billion, against about USD 82.8 billion for Lumentum, so the target would be about a third of the buyer's size. Lumentum (NASDAQ:LITE) is the proposed target.
  • Lumentum shares rose between 2.5% and 5% depending on the timestamp, a range that reflects different quotes and not a confirmed deal premium or any agreed price.

What Was Reported

A media report said on October 29, 2026 that Marvell (NASDAQ:MRVL) is in advanced talks to buy Lumentum, and that an announcement could come as soon as next week. This is a report and not a confirmed event: no company statement, filing or press release has been found, and the price, form of payment and timing are not known. Marvell shares fell about 13% to USD 218.95, while Lumentum rose by 2.5% to 5% in different quotes. The market capitalization figures of just over USD 220 billion for Marvell and about USD 82.8 billion for Lumentum come from published market data. The relative size, about 37%, is simple arithmetic on those two figures.

Why Acquirers Often Fall

The share price of a buyer often declines when a large deal is reported, because investors worry that it will pay a premium, issue stock or add debt. If Marvell (NASDAQ:MRVL) paid with shares, current holders would be diluted, which means their stake becomes a smaller share of a larger company. The seller usually rises because buyers pay above the market price, which fits the Lumentum gain. Whether the reported deal makes strategic sense, for example by adding optical components to a chip business, was not confirmed here and is not stated. The fall is also part of a wide technology sell-off, as Intel, Amazon and Dell fell sharply on the same news cycle.

Risks and What to Watch

The main risk is uncertainty: talks can fail, change in price or never lead to an announcement, and a reported deal is not a signed one. If a deal arrives, regulators in several countries may review it, which can take many months. Marvell (NASDAQ:MRVL) could also face more selling if investors dislike the price or the strategic fit, even before any signed agreement. Readers should watch for a company release or an 8-K filing, which would be the primary source. Also watch the 9:30 a.m. ET open on October 30, analyst notes on deal logic, and Apple on Monday, November 2, which can move the wider technology group. Midterm elections follow on November 3, 2026.

Where Things Stand

Marvell (NASDAQ:MRVL) fell because a media report of advanced talks to buy Lumentum raised fears about price, dilution and integration. The deal is reported and not confirmed, so the evidence is limited to price moves and one report. If it is announced next week, the terms will matter more than the headline, and a denial or continued silence would also move the stock, so the next several days carry more weight than usual.